Dudediligence.

Krystal Biotech, Inc

KRYSNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$83.8MSep ’24$91.1MDec ’24$88.2MMar ’25$96.0MJun ’25$97.8MSep ’25$107.1MDec ’25$116.4MMar ’26$119.2MJun ’26
Net income, by quarter
$27.2MSep ’24$45.5MDec ’24$35.7MMar ’25$38.3MJun ’25$79.4MSep ’25$51.4MDec ’25$55.9MMar ’26$54.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$0.00$0.00$50.7M$290.5M$389.1M
Operating income−$68.3M−$145.2M−$109.6M$65.7M$161.3M
Net income−$69.6M−$140.0M$10.9M$89.2M$204.8M
Operating cash flow−$47.9M−$100.6M−$88.8M$123.4M$200.9M
Free cash flow−$116.3M−$153.5M−$100.6M$119.2M$188.9M
Cash$341.2M$161.9M$358.3M$344.9M$496.3M
Shares outstanding25.2M25.8M28.2M28.8M29.2M